학술논문
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Tocilizumab, An Interleukin-6 Receptor Antibody, for Residual Symptoms in Schizophrenia
Document Type
Article
Author
Source
In: Neuropsychopharmacology . (Neuropsychopharmacology, 1 May 2018, 43(6):1317-1323)
Subject
Language
English
ISSN
1740634X
0893133X
0893133X